SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
紧张的绮梅
Lv0
0 积分
2024-04-25 加入
最近求助
最近应助
互助留言
A Novel Engineering Cell Therapy Platform Mimicking the Immune Thrombocytopenia‐Derived Platelets to Inhibit Cytokine Storm in Hemophagocytic Lymphohistiocytosis
9小时前
已完结
An open‐label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome
5天前
已完结
Case report: Successful treatment with tofacitinib and colchicine in a patient with Schnitzler syndrome
11天前
已完结
Case report: Successful treatment with tofacitinib and colchicine in a patient with Schnitzler syndrome
16天前
已完结
Development of novel humanized CD19/BAFFR bicistronic chimeric antigen receptor T cells with potent antitumor activity against B-cell lineage neoplasms
2个月前
已完结
How do we manage t(11;14) plasma cell disorders with venetoclax?
3个月前
已完结
Prognostic Implications of Circulating Plasma Cell Percentage in Multiple Myeloma and Primary Plasma Cell Leukemia Defined by New Criteria
4个月前
已关闭
Venetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expression
4个月前
已完结
没有进行任何应助
感谢
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论